Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Litfulo 50mg Hard Capsules {equilateral_black_triangle}

Active Ingredient:
ritlecitinib tosylate
Company:  
Pfizer Limited See contact details
ATC code: 
L04AF08
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Litfulo (ritlecitinib) Patient Card

Litfulo Patient Card
{pdf_link}

Litfulo (ritlecitinib) Prescriber Guide

{healthcare_pro_orange} For Healthcare Professionals
Prescriber guide to provide a checklist for assessments prior to prescribing, management, monitoring and safety considerations related to the Risk Management Plan

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Pfizer Limited
Company image
Address
Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone
+44 (0)1304 616 161
Medical Information Website
www.pfizermedicalinformation.co.uk
Medical Information Direct Line
+44 (0)1304 616161